Jean‐François Baladi

Author

Also Known As

Jean-Francois Baladi, Jean-François Baladi, Jean-François Baladi, Jeanfrancois Baladi, Jean‐Francois Baladi, Jean‐François Baladi

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (Switzerland)Children's Hospital of Los Angeles Mapi Research Trust University College London

About

Jean‐François Baladi is an author at Novartis (United States) specializing in medicine, health policy, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	711
2	Business	1	1	44
3	Education	1	1	44
4	Nursing	1	1	35
5	Public Health	1	1	266

Jean‐François Baladi

Publications

Citations

H-Index

Page 1

	Year	Citations
Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs Theodore Darkow, Henry J. Henk, Simu K. Thomas, PharmacoEconomics Health PolicyTreatment And PreventionPatient SafetyTreatment OptionOutcomes Research	2007	266
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia Maria Domenica Cappellini, Mohamed Béjaoui, Leyla Ağaoğlu, Clinical Therapeutics AnemiaPatient-reported OutcomesIron MetabolismIron OverloadHematology	2007	118
Cost Effectiveness of Once-Daily Oral Chelation Therapy with Deferasirox versus Infusional Deferoxamine in Transfusion-Dependent Thalassaemia Patients Thomas E. Delea, Oleg Sofrygin, Simu K. Thomas, PharmacoEconomics Infusional DeferoxamineTranslational MedicineMedicineTransfusion MedicineHematology	2007	78
Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload Krista Payne, Diana Rofail, Jean‐François Baladi, Advances in Therapy Health EconomicsHealth PolicyIron MetabolismIron OverloadIron Chelation Therapy	2008	72
ECONOMIC ANALYSIS OF BASILIXIMAB IN RENAL TRANSPLANTATION1 Paul Keown, Robert Balshaw, Hans Krueger, Transplantation	2001	61
Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis Elliott Vichinsky, Zahra Pakbaz, Onyinye Onyekwere, Acta Haematologica	2008	60
An Economic Evaluation of Finasteride for Treatment of Benign Prostatic Hyperplasia Jean‐François Baladi, Devidas Menon, Nicolaas Otten PharmacoEconomics UrologyPharmacologyPharmacoeconomicsBenign Prostatic HyperplasiaPharmacotherapy	1996	53
Clinical and economic burden of infused iron chelation therapy in the United States Krista Payne, Marie‐Pierre Desrosiers, J. Jaime, Transfusion	2007	45
Disease management patterns for postmenopausal women in Europe with hormone-receptor-positive, human epidermal growth factor receptor-2 negative advanced breast cancer Fabrice André, Patrick Neven, Nina Marinsek, Current Medical Research and Opinion	2014	45
Use of economic evaluation guidelines: 2 years’ experience in Canada Jean‐François Baladi, Devidas Menon, Nicolaas Otten Health Economics Economic AssessmentEducationResearch EvaluationPolicy AnalysisQuality Evaluation	1998	44

Page 1